:TAVI

Patrick Badertscher1, Stefan Stortecky2, Teodor Serban1

  • 1Department of Cardiology, University Hospital Basel, Basel, Switzerland; Cardiovascular Research Institute Basel, University Hospital Basel, Basel, Switzerland.

概括

跨导管大动脉置换 (TAVR) 后的心脏起器植入与显著更高的长期死亡率有关. 需要心脏起器的患者在TAVR后面临死亡和心血管事件的风险增加,长达10年.